Atlas Trials

Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)

Clinical trial NCT00705198 · COMPLETED

Trial details

NCT number
NCT00705198
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Study type
OBSERVATIONAL
GliomaAstrocytoma
Start date
2006-09-01
Primary completion
2016-07-01
Enrollment
1804

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.